This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Campbell's Plans Post Strategic Review Revive the Stock?
by Zacks Equity Research
Campbell (CPB) unveils various actions as part of its prudent portfolio review and Board-led strategy, aiming at improving performance that has been drab otherwise.
5 Reasons Why Helen of Troy Stock Must be in Your Portfolio
by Zacks Equity Research
Helen of Troy (HELE) is likely to keep its stellar show on, evident from its raised earnings outlook for fiscal 2019.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
Church & Dwight's International Unit Strong, Margins Soft
by Zacks Equity Research
Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. However, gross margin has been declining for a while now.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
by Nitish Marwah
Trump's pro-growth agenda has worked wonders for the economy as a whole.
Dean Foods Dips to a 52-Week Low, Input Costs a Key Concern
by Zacks Equity Research
Dean Foods (DF) is fighting obstacles related to input cost inflation, tepid volumes and higher retailer investments in the private label space, weighing on its performance.
Campbell (CPB) Sees Soft Q4 Earnings, Unveils Strategic Plans
by Zacks Equity Research
Campbell's (CPB) earnings fall due to higher tax rate, lower adjusted EBIT on base business and more. The company unveils various actions to improve business as part of strategic portfolio review.
Hain Celestial (HAIN) Q4 Earnings Decline Y/Y, Stock Down
by Zacks Equity Research
Hain Celestial (HAIN) witnesses the third straight quarter of sales miss in Q4. Also, high promotional and trade investments along with freight costs hurt gross margin.
Tyson Foods Down 10% in 3 Months, Market Volatility a Worry
by Zacks Equity Research
Tyson Foods' (TSN) Chicken and Pork segment witness unstable market conditions stemming from increased tariffs.
Anatomy of Success: Medifast Inc. (MED)
by Madeleine Johnson
This Zacks Rank #1 stock skyrocketed over +130% in just six months.
Sanderson Farms (SAFM) Q3 Earnings & Sales Fall Year on Year
by Zacks Equity Research
Sanderson Farms' (SAFM) Q3 results are negatively impacted by lower average selling prices and increased costs of sales.
Hormel Foods (HRL) Stock Down 5% Despite Q3 Earnings Beat
by Zacks Equity Research
Hormel Foods' (HRL) top and bottom lines improve year over year in Q3. However, sales lag estimate and management cuts sales outlook.
Hershey Up More Than 10% in 3 Months: More Room for Growth?
by Zacks Equity Research
Hershey (HSY) is gaining from its buyout of Amplify, focus on productivity improvements and brand strength. However, escalated costs remain a threat to margins.
Clorox (CLX) Surges 24% in 3 Months: More Room to Run?
by Zacks Equity Research
Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
Can Dean Foods' Cost-Cutting Plans Provide Respite to Stock?
by Zacks Equity Research
Dean Foods (DF) has been taking steps to reduce unnecessary costs and improve efficiency. These initiatives should help offset some negative impacts from volume declines and higher input costs.
Archer Daniels (ADM) Up 26% YTD: Will the Momentum Continue?
by Zacks Equity Research
Archer Daniels (ADM) looks promising backed by cost-savings efforts and management of its business portfolio. The company has an impressive earnings surprise trend as well.
Buy These 5 Low-Beta Stocks to Brave Market Volatility
by Zacks Equity Research
In this article, we have come up with an investment strategy that clearly shows that less risky securities can also generate handsome returns if some parameters are considered.
Helen of Troy Up Post Q1: Earnings Beat Not the Sole Factor
by Zacks Equity Research
Helen of Troy (HELE) has been gaining from its consistent online sales and digital marketing efforts. Strength in Leadership Brands and Project Refuel has also been driving performance.
Church & Dwight (CHD) Up 20% in 3 Months: More Room to Run?
by Zacks Equity Research
The company has outpaced the industry in the past three months, gaining from its focus on buyouts, robust international business and innovations.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Sysco (SYY) Looks Good: Stock Adds 6.2% in Session
by Zacks Equity Research
Sysco (SYY) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Tyson Foods' (TSN) Sale of Pizza Crust Unit to Drive Growth
by Zacks Equity Research
Tyson Foods (TSN) inks a deal to offload its pizza crust business to an affiliate of Peak Rock Capital. The agreement, which includes the sale of TNT Crust, is expected to close in September.